CDC Director Deeply Concerned By Teen COVID-19 Hospitalization Rate – HuffPost

The Centers for Disease Control and Prevention is now urging parents of teens to get them vaccinated against COVID-19 after a new report underscored the severe health effects the virus can have on adolescents.

The agency’s weekly morbidity and mortality report, released Friday, showed a rising rate of hospitalization for COVID-19 patients in the 12-to-17-year-old range, possibly driven by more transmissible variants and the return to in-person schooling.

“I am deeply concerned by the numbers of hospitalized adolescents and saddened to see the number of adolescents who required treatment in intensive care units or mechanical ventilation,” CDC Director Rochelle Walensky said Friday.

“Much of this suffering can be prevented,” she added. 

Most COVID-19 hospitalizations occur in older adults. Yet between March and April, adolescent hospitalization rose from 0.6 cases per 100,000 to 1.3 cases per 100,000. Nearly a third of adolescents who required hospitalization while they fought off COVID-19 infections also required intensive care, the study showed, and 5% required mechanical ventilation. Two-thirds were Black or Hispanic — a reminder of the outsized toll the virus has taken on communities of color — and around 30% reported no underlying medical conditions.

None of the adolescents died. 

Still, Walensky cautioned parents against moving away from preventative health care measures ― such as using masks and distancing ― until their children were fully protected by the vaccine. 

“I ask parents, relatives and close friends to join me and talk with teens about the importance of these prevention strategies and to encourage them to get vaccinated,” she said. “Vaccination is our way out of this pandemic.” 

The report noted that transmission “occurs more easily” in high schools compared to elementary schools, particularly among kids participating in extracurricular activities. 

In May, the CDC approved the Pfizer vaccine for use in people age 12 and up; the Moderna and Johnson & Johnson drugs are currently approved for those age 18 and up.